Paper Details

  1. Home
  2. Paper Details

Selective Progesterone Receptor Modulators for the Treatment of Uterine Leiomyomas.

Author: ChillHenry H, Reuveni SalzmanAdi, SafraiMyriam, ShushanAsher

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Selective progesterone receptor modulators are a promising new treatment option for uterine leiomyomas, which are common benign uterine tumors that can cause prolonged menstrual bleeding, pelvic pressure, and reproductive disorders. They have shown promising results in shrinking uterine leiomyomas and providing a prolonged clinical effect.
Paper Details　
Original Abstract of the Article :
Uterine leiomyomas have drawn much attention since being described more than 200 years ago. These common benign uterine tumors often present with prolonged menstrual bleeding, pelvic pressure, and reproductive disorders and pose a true financial burden on health care systems all over the world. Over...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/28697115

データ提供：米国国立医学図書館（NLM）

Selective Progesterone Receptor Modulators: A New Era for Uterine Leiomyomas

The field of [gynecology] is constantly striving to find better ways to manage [uterine leiomyomas], a common condition affecting women. This research explores the potential of [selective progesterone receptor modulators (SPRMs)] as a new treatment option for [uterine leiomyomas]. The research highlights the promise of SPRMs in shrinking [uterine fibroids] and providing long-term relief from symptoms, offering hope for women seeking non-surgical solutions.

SPRMs: A Promising New Frontier in Uterine Leiomyoma Treatment

This research presents a compelling case for the use of [SPRMs] in treating [uterine leiomyomas]. The study suggests that SPRMs hold significant promise for shrinking fibroids and providing long-term relief from associated symptoms. These findings offer a potential alternative for women seeking non-surgical treatment options for this common condition.

Living with Uterine Leiomyomas: Exploring Treatment Options

This research provides valuable insights into the potential benefits of [SPRMs] for women with [uterine leiomyomas]. The study highlights the importance of consulting with a gynecologist to discuss all available treatment options and to determine the best approach based on your individual needs. It underscores the need for a personalized approach to treatment and the importance of prioritizing your health and well-being.

Dr.Camel's Conclusion

This research is like discovering a hidden oasis in the desert of uterine fibroid treatment options! SPRMs offer a promising new avenue for managing this condition, providing hope for women seeking non-surgical solutions. It's important to consult with a gynecologist to discuss all available options and to find the best path for your individual needs.

Date :
  1. Date Completed 2017-08-21
  2. Date Revised 2021-01-08
Further Info :

Pubmed ID

28697115

DOI: Digital Object Identifier

00006250-201708000-00009

Related Literature

Article Analysis
・Side Effects of ulipristal
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.